AVADEL PHARMACEUTICALS PLC's ticker is AVDL and the CUSIP is 05337M104. A total of 86 filers reported holding AVADEL PHARMACEUTICALS PLC in Q1 2022. The put-call ratio across all filers is 0.45 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $3,961,000 | +61.7% | 580,000 | +132.0% | 1.85% | +114.2% |
| Q3 2021 | $2,450,000 | -35.1% | 250,000 | -55.4% | 0.86% | -42.7% |
| Q2 2021 | $3,776,000 | -61.9% | 561,011 | -48.8% | 1.51% | -57.7% |
| Q1 2021 | $9,899,000 | +110.1% | 1,095,000 | +55.3% | 3.57% | +178.4% |
| Q4 2020 | $4,711,000 | +32.6% | 705,218 | 0.0% | 1.28% | +32.8% |
| Q3 2020 | $3,554,000 | -74.9% | 705,218 | -59.8% | 0.96% | -76.4% |
| Q2 2020 | $14,158,000 | -32.4% | 1,752,218 | -34.5% | 4.09% | -59.7% |
| Q1 2020 | $20,949,000 | +70.7% | 2,673,718 | +64.5% | 10.15% | +234.2% |
| Q4 2019 | $12,269,000 | – | 1,625,000 | – | 3.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WEALTH EFFECTS LLC | 2,305,017 | $18,625,000 | 7.73% |
| COWEN AND COMPANY, LLC | 3,732,778 | $30,161,000 | 2.74% |
| GENDELL JEFFREY L | 2,446,299 | $19,766,000 | 1.60% |
| Asymmetry Capital Management, L.P. | 369,134 | $2,983,000 | 1.58% |
| Vivo Capital, LLC | 2,937,093 | $23,732,000 | 1.43% |
| Samsara BioCapital, LLC | 659,409 | $5,328,000 | 1.03% |
| Altium Capital Management LP | 440,589 | $3,560,000 | 0.98% |
| Knott David M Jr | 258,198 | $2,086,000 | 0.71% |
| RTW INVESTMENTS, LP | 5,741,939 | $46,395,000 | 0.68% |
| FRAZIER MANAGEMENT LLC | 951,814 | $7,691,000 | 0.59% |